2-(3-(3,5-DIMETHOXYPHENOXY)PROPYL)ISOINDOLINE-1,3-DIONE, 95.0%, 500mg

Betamethasone disodium phosphate, 10g

(S)-2,2'-bis(Diphenylphosphino)-1,1'-binaphthyl monooxide, 95%, 100mg

3-Bromo-5-iodobenzonitrile, 95.0%, 5g

2-ETHOXY-4-METHOXY-1-NITRO-BENZENE, 95.0%, 250mg

Ácido caprónico, mínimo 98 %, para síntesis, 500 ml, envase de vidrio

(1S,4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol, 98%, 1g

4-Bromo-3-methoxy-5-methylthiophene-2-carboxylic acid, 95%, 250mg

(S)-1-(PYRIMIDIN-2-YL)PYRROLIDINE-2-CARBOXYLIC ACID, 95.0%, 250mg

3M (TM) Novec(TM) Engineered Fluid HFE-7100, 1kg

1-(4-Chlorophenyl)-2-fluoroethanone, 95.0%, 500mg

Butylamine Hydrobromide>98.0%(N)(T)5g

3-METHYL-4-MORPHOLINOPHENYLBORONIC ACID, 97.0%, 1g